Delivery Order SPE2DB20D3101-SPE2DB24FRVM8

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,527.92 firm fixed-price delivery order is for the supply of ARNUITY ELLIPTA 100 MCG INH 30S, a respiratory medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,030.94 firm fixed price delivery order is for the supply of ARNUITY ELLIPTA 100 MCG INH 30S medical inhalation products. The award is not designated under any set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $1,324.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARNUITY ELLIPTA 100 MCG INH 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order that runs through July 2, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,961.16, is for the delivery of ARNUITY ELLIPTA 200 MCG INH 30S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside and was awarded on an open competition basis. AmerisourceBergen...
This federal contract award, valued at $1,834.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARNUITY ELLIPTA 100 MCG INH 30S, a medical commodity to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award with ID SPE2DB20D3103|SPE2DB24FN8P2 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,783.94 firm fixed-price delivery order is for the pharmaceutical product ARNUITY ELLIPTA 100 MCG INH 30S. The contract has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,670.85, is a firm fixed-price delivery order for ARNUITY ELLIPTA 100 MCG INH 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
The Defense Logistics Agency (DLA) awarded a $1,134.45 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the procurement of 4563954014 ARNUITY ELLIPTA 100 MCG INH 30S. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a $2,791.31 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARNUITY ELLIPTA 100 MCG INH 30S, a pharmaceutical product, with a period of performance through June 13, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $3,279.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ARNUITY ELLIPTA 200 MCG INH 30S, a pharmaceutical product, and has a completion date of June 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp, a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRVM8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,567.32 firm fixed price delivery order is for ARNUITY ELLIPTA 100 MCG INH 30S, a respiratory medication. The contract has an ultimate completion date of September 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, both of which cover a range of pharmaceutical and medical supply products. This contract award was not designated with a set-aside requirement.

Generated 2/27/25, 12:18 PM